Bitcoin at $61,000: 3 Better Cryptocurrencies to Buy Now
Bitcoin is posting a stellar performance despite volatility. These cryptocurrencies could be even better.
3 Inflation-Proof Dividend Stocks Begging to Be Bought
More inflation is coming. Don't get left behind.
3 Explosive Stocks to Buy Right Now
Powered by stellar sales growth, these stocks could be headed for the moon.
2 Robinhood Stocks to Buy in October
These popular stocks are trading at discounts from their recent highs.
3 Top Stocks to Buy in 2021 and Hold for the Next Decade
Buying these stocks in the fourth quarter could make your year.
2 No-Brainer Stocks to Buy With $1,000 Right Now
These industry leaders look attractive from a risk vs. reward perspective.
Here's Why Solana Is Gaining Today
Solana's SOL token has surged more than 12,000% this year.
Got $1,000? 2 Warren Buffett Stocks to Buy
These Buffett favorites could strengthen your portfolio.
Why Cosmos' ATOM Cryptocurrency Is Climbing
The ATOM token has skyrocketed more than 540% year to date.
Got $500? 2 Dirt-Cheap Stocks to Buy Right Now
These beaten-down tech stocks have explosive upside.
Here's Why Dogecoin Is Falling Today
The popular Shiba Inu themed crypto token is sliding. What does it mean for investors?
Got $5,000? These 2 Growth Stocks Are Smart Buys
These industry leaders could deliver big wins for shareholders.
Here's Why UP Fintech Stock Plummeted This Week
After some volatile swings, UP Fintech stock is now roughly flat across 2021's trading.
Here's Why PagSeguro Digital Stock Is Jumping
Even with a recent rebound, the Brazilian fintech stock is down 35% year to date.
3 Top Warren Buffet Stocks to Buy in October
These Buffett-backed stocks could help take your portfolio to the next level.
3 Dependable High-Yield Dividend Stocks to Buy Hand Over Fist Right Now
High yield and attractive valuations? Yes, please.
Why CRISPR Therapeutics Stock Fell 10.4% Last Month
CRISPR Therapeutics stock is now down roughly 33% across 2021's trading.
Why Appian Stock Fell 13.7% Last Month
The low-code software specialist's stock is now down roughly 45% in 2021.
Why AbCellera Biologics Stock Jumped 19.4% Last Month
Despite last month's gains, the biotech stock is now down roughly 61% year to date.
Why Focus Universal Stock Is Making Big Gains
Despite volatile swings, Focus Universal stock is now up more than 135% year to date.